SCHEMBL22953954

SCHEMBL22953954

Oc1ccc(CN[C@H]2CCc3cc(O)c(O)cc3C2)cc1O

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 1/20 0.57
▸ GRIN2B Q13224 3/20 0.50
▸ DRD2 P14416 4/20 0.45
▸ DRD3 P35462 3/20 0.45
▸ DRD4 P21917 1/20 0.45
▸ ERCC1 P07992 2/20 0.43
▸ ERCC4 Q92889 2/20 0.43
▸ MAPT P10636 2/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ THPO P40225 1/20 0.42
▸ HIF1A Q16665 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ARG1 P05089 1/20 0.41
▸ DRD1 P21728 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22953958 0.89 FYN (0.52) FYNGRIN2BDRD2DRD3DRD4
SCHEMBL14494801 0.85 FYN (0.80) FYNGRIN2BDRD2DRD3
SCHEMBL13868598 0.81 ERCC1 (0.53) FYNERCC1ERCC4MAPTALDH1A1
SCHEMBL7279623 0.79 ADRA1A (0.54) GRIN2BDRD2DRD3DRD4DRD1
Bromide SCHEMBL7281334 0.78 ADRA1A (0.53) GRIN2BDRD2DRD3DRD4DRD1
SCHEMBL8346672 0.76 HRH3 (0.61) ERCC1ERCC4ALDH1A1KDM4EARG1
SCHEMBL7271830 0.75 DRD2 (0.52) FYNGRIN2BDRD2DRD3DRD4
Bromide SCHEMBL7281324 0.73 GRIN2B (0.41) GRIN2BDRD2DRD3DRD4MAPT
SCHEMBL11022881 0.73 FYN (0.45) FYNGRIN2BDRD2DRD3DRD4
Hydrochloric Acid SCHEMBL7356162 0.73 DRD2 (0.69) FYNDRD2DRD3DRD4DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021953-A2 DOPAMINE RECEPTOR D1 AGONISTS AND METHODS OF USE Sanford Burnham Prebys Medical Discovery Institute (US) 2021-02-04 — — WO disclosed
Send feedback